Document is current
Any future updates will be listed below
-
Authors
Goyal, Ravi K. https://orcid.org/0000-0003-1632-036X
Zhang, Jingchuan
Davis, Keith L.
Sluga-O’Callaghan, Martina
Kaufman, Peter A. https://orcid.org/0000-0003-3677-6807
-
Funding
Funding for this research was provided by:
Eisai Incorporated (N/A)
- License Information
-
More Information
Article History
Received: 17 May 2023
Accepted: 9 August 2023
First Online: 4 February 2024
Declarations
:
: The Research Triangle Institute Institutional Review Board (IRB) granted this study waiver from full IRB review or informed consent from patients.
: Not applicable.
: Not applicable.
: RKG, KLD, and MSO are full-time employees of RTI Health Solutions, an independent nonprofit research organization, which was retained by Eisai Inc. to conduct the research that is the subject of this manuscript. Their compensation is unconnected to the studies on which they work. JZ is an employee of Eisai Inc. PAK received research support and/or served as a consultant/advisor for the following: Eisai Inc., Roche/Genentech Amgen, Novartis, Macrogenics, Polyphor, Lilly, Pfizer, Sanofi, Bristol-Myer Squibb, H3 BioMedicine, Zymeworks Therapeutics, and AstraZeneca.
